Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Denosumab to Prevent Bone Loss in Ambulatory and Non-ambulatory Motor-Incomplete Patients With Subacute Spinal Cord Injury

NCT03029442 is registered in ClinicalTrials.gov with James J. Peters Veterans Affairs Medical Center as lead sponsor.

NCT NCT03029442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03029442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Denosumab to Prevent Bone Loss in Ambulatory and Non-ambulatory Motor-Incomplete Patients With Subacute Spinal Cord Injury
Lead sponsor
James J. Peters Veterans Affairs Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
April 1, 2017
Completion date
October 6, 2022
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

secondary osteoporosis, spinal cord injury